Topic: Medical device IPO
Spinal fusion implant company SpineEX filed for a $17.25 million initial public offering on the Nasdaq, planning to list under the ticker symbol SPIX.
Former Fierce 15 winner MaxQ plans to go public with $8 million IPO, as it awaits FDA approval of its AI tech for analyzing CT scans for brain bleeds.
Xeris Pharmaceuticals plans to go public, filing for a $75 million IPO to fund an NDA submission this year for its glucagon rescue pen.
The plan is to use the IPO money to introduce a string of new products over the next few years.
Molecular diagnostics firm Quanterix is launching an IPO. The move comes more than a year after the company locked down funding to spur growth.
The IPO filing comes days after the U.K. startup acquired licenses to make and sell Stryker medical devices.
Days after the FDA approved Optinose’s nasal polyp drug, its commercialization will be the focus of a post-IPO spending spree.